Kura Oncology KURA
NASDAQ KURA
$10.65 -0.06 (-0.56%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kura Oncology (KURA) Asset Utilization Ratio (2025 - 2026)

Updated

Kura Oncology's Asset Utilization Ratio was 0.12 in Q2 2026, up 20.9% from the prior quarter.

Analysis

Kura Oncology (KURA) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at Kura Oncology came in at 0.09, up 1.0% from FY2024.

  • In earlier years, Asset Utilization Ratio was 0.09 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.49
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.47
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.52
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.44
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.53
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.40
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.58
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 0.47
10 Kura Oncology 952.70 Mn 952.70 Mn 20.63 Mn 0.12
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.12
Mar 31, 2026 0.10
Dec 31, 2025 0.10
API Access

Kura Oncology Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=KURA&period=max&api_key=YOUR_API_KEY